It is also noteworthy that none of our recruited patients with O6-methylguanine-DNA methyltransferase (MGMT)-positive glioblastomas were treated with tumor-treating fields, while this treatment method should additionally be offered to each eligible patient [14-17]. The gene discussed is MGMT; the disease is glioblastoma.